Croatia below EU average in use of biosimilar drugs

Croatia is below the EU average in the use of biosimilar drugs, which are much cheaper and more available than original biologic drugs, a conference heard earlier this week, organised to mark ten years of the use of biosimilars in Croatia's healthcare. Pročitaj više